Description
Pacliget 260mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient is Paclitaxel, a potent chemotherapeutic agent. Paclitaxel works by interfering with the normal function of microtubules, which are essential components of cell division. By stabilizing microtubules, it prevents the breakdown necessary for cancer cells to divide and multiply, ultimately leading to cell death. Pacliget 260mg Injection is indicated for the treatment of advanced ovarian cancer, advanced breast cancer, and non-small cell lung cancer, often in combination with other chemotherapy drugs. The dosage and administration of Pacliget 260mg Injection are determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health. Common side effects may include bone marrow suppression (leading to low blood cell counts), peripheral neuropathy (nerve damage causing numbness or tingling), hair loss, nausea, vomiting, and allergic reactions. It is crucial to report any unusual or severe side effects to your doctor immediately. Pacliget 260mg Injection should be stored at room temperature and protected from light. It is administered intravenously under strict medical supervision.
